Krebiozen
Krebiozen (also known as Carcalon) is a controversial substance that was promoted as a cancer treatment in the 1950s and 1960s. The substance was introduced by Dr. Andrew C. Ivy, a prominent physiologist and vice president of the University of Illinois. Despite initial claims of its effectiveness, subsequent scientific studies found no evidence that Krebiozen has any beneficial effect on cancer.
History[edit | edit source]
Krebiozen was first introduced in the United States in 1951 by Dr. Andrew C. Ivy. The substance was reportedly discovered by Dr. Stevan Durovic, a Yugoslavian doctor who claimed that it was an extract from horse blood that could cure cancer. Dr. Ivy, impressed by Durovic's claims, began promoting Krebiozen as a miracle cure for cancer.
Controversy[edit | edit source]
The promotion of Krebiozen as a cancer treatment led to one of the most controversial medical debates of the 20th century. The American Medical Association and the Food and Drug Administration (FDA) both challenged the claims made by Dr. Ivy and Dr. Durovic. In 1963, the FDA seized all supplies of Krebiozen and charged Dr. Ivy and Dr. Durovic with fraud. The case went to trial in 1966, and after a lengthy legal battle, the doctors were acquitted.
Scientific Evaluation[edit | edit source]
Numerous scientific studies have evaluated the effectiveness of Krebiozen as a cancer treatment. These studies have consistently found no evidence that Krebiozen has any beneficial effect on cancer. The American Cancer Society has stated that "Krebiozen is considered ineffective as a treatment for cancer by the medical community."
Legacy[edit | edit source]
Despite the lack of scientific evidence supporting its effectiveness, Krebiozen remains a topic of interest in the history of cancer treatment. The controversy surrounding Krebiozen highlights the importance of rigorous scientific evaluation and regulatory oversight in the development and promotion of new medical treatments.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD